News

Technology News

ALung Technologies Adds Venture Capital Debt

Thursday, January 14, 2016 5:01:00 AM PDT | VentureDeal
   Pittsburgh, Pennsylvania  --  Medical device technology company ALung Technologies has secured $4 million in venture capital debt funding, according to an SEC regulatory filing.

ALung has developed a family of gas exchange devices for the treatment of acute and chronic respiratory disorders such as emphysema/COPD.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

ALung is still seeking $1.16 million in additional debt investment, according to the filing.

Chairman and CEO Peter DeComo has been with the firm since January 2009. Mr. DeComo is a board member of the Pittsburgh Life Sciences Greenhouse.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1